Said, M.M.; Broen, M.P.G.; Swart, E.L.; Bartelink, I.H.; Kouwenhoven, M.C.M.
Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach? Cancers 2023, 15, 1561.
https://doi.org/10.3390/cancers15051561
AMA Style
Said MM, Broen MPG, Swart EL, Bartelink IH, Kouwenhoven MCM.
Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach? Cancers. 2023; 15(5):1561.
https://doi.org/10.3390/cancers15051561
Chicago/Turabian Style
Said, Medhat M., Martinus P. G. Broen, Eleonora L. Swart, Imke H. Bartelink, and Mathilde C. M. Kouwenhoven.
2023. "Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?" Cancers 15, no. 5: 1561.
https://doi.org/10.3390/cancers15051561
APA Style
Said, M. M., Broen, M. P. G., Swart, E. L., Bartelink, I. H., & Kouwenhoven, M. C. M.
(2023). Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach? Cancers, 15(5), 1561.
https://doi.org/10.3390/cancers15051561